Ryzneuta (Efbemalenograstim Alfa-Vuxw) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Ryzneuta. Always confirm against the full prescribing information.
5 interactions
Cyclophosphamide
The risk or severity of pulmonary toxicity can be increased when Efbemalenograstim alfa is combined with Cyclophosphamide.
Level 1 evidence
Topotecan
The risk or severity of neutropenia can be increased when Efbemalenograstim alfa is combined with Topotecan.
Level 1 evidence
Vinblastine
The risk or severity of peripheral neuropathy can be increased when Efbemalenograstim alfa is combined with Vinblastine.
Level 2 evidence
Vincristine
The risk or severity of peripheral neuropathy can be increased when Efbemalenograstim alfa is combined with Vincristine.
Level 2 evidence
Vinorelbine
The risk or severity of peripheral neuropathy can be increased when Efbemalenograstim alfa is combined with Vinorelbine.
Ryzneuta (Efbemalenograstim Alfa-Vuxw) has 5 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Ryzneuta (Efbemalenograstim Alfa-Vuxw) has 0 major, 5 moderate, and 0 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Ryzneuta. Always confirm against the full prescribing information.